MSLN and pancreatic neoplasm: Mesothelin (MSLN), a 40‐kDa glycosylphosphatidyl inositol‐linked protein, is highly expressed in many solid tumors, including pancreatic cancer (80‐85%), while its expression is limited in normal tissues.